Health
China’s Covid-19 vaccine candidate proves safe in initial tests – Hindustan Times
Scientists have said that despite the vaccine proving safe, no data to establish the final efficacy.
Researchers in China have confirmed that BBIBP-CorV, a vaccine currently under human trial observation, has safely triggered the expected antibody immune responses.
The combined early and mid-stage trials for the vaccine happened between April 29 and July 30 this year.
Beijing Institute of Biological Products, a subsidiary of China National Biotec Group (CNBG), is currently developing the vaccine. It is one of ten potential vaccine candidates that have entered the Phase III trials around the …
-
Business18 hours agoWarning! These ASX 200 shares were just downgraded
-
Business10 hours agoMacquarie tips 14% upside for this ASX tech stock
-
General6 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase
-
Noosa News11 hours agoVegetables and herbs you can easily and cheaply grow from seeds